Eli Lilly India gets nod for emergency use of antibody drugs combination for COVID-19

The company has received permission for restricted emergency use of its monoclonal antibody drugs, bamlanivimab 700 mg and etesevimab 1400 mg, used together for the treatment of patients with mild to moderate COVID-19, Eli Lilly said in a statement.